Blood marker may reveal kidney trouble early in heart failure patients
NCT ID NCT00561483
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study looked at 64 adults hospitalized for acute heart failure to see if a blood marker called cystatin C could detect early kidney problems caused by diuretic treatment. Researchers measured cystatin C levels daily and compared them to standard kidney tests. The goal was to understand how kidney function changes during treatment and whether cystatin C could help predict worsening kidney function in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 21-Protein blood test aims to spot hidden heart failure in the ER
- Kidney filter study tests safer dialysis for acute kidney failure
- Music may soothe dialysis discomfort
- Hospital heart pill may prevent repeat crises
- Dialysis showdown: which blood thinner works best?
- New device aims to keep dialysis fistulas working longer